Mathieu Bourdenx

7.0k citations

32 papers · 2.2k indexed · 3 hit papers · h-index 21

Impact in

Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Aging top 5%

Papers in ⓘ

Aging 2
Neurology 17
- Parkinson's Disease Mechanisms and Treatments 17
- Neurological disorders and treatments 5

Co-authors: Benjamin Dehay (18 shared papers)Erwan Bézard (21 shared papers)Ana María Cuervo (5 shared papers)Olatz Pampliega (2 shared papers)Aurora Scrivo (2 shared papers)Wassilios G. Meissner (5 shared papers)Federico N. Soria (2 shared papers)Miquel Vila (3 shared papers)
Journals: Neurobiology of Disease (3 papers)Autophagy (2 papers)Scientific Reports (2 papers)Nature Cell Biology (2 papers)PLoS Biology (2 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Mathieu Bourdenx

32 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

The different autophagy degradation pathways and neurodegeneration 2022 · 293 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Neuron
2018 The Lancet Neurology
2015 The Lancet Neurology

Peers

Countries citing papers authored by Mathieu Bourdenx

Since Specialization

Citations

This map shows the geographic impact of Mathieu Bourdenx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Bourdenx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Bourdenx more than expected).

Fields of papers citing papers by Mathieu Bourdenx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Bourdenx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Bourdenx. The network helps show where Mathieu Bourdenx may publish in the future.

Co-authors

The 25 scholars most cited alongside Mathieu Bourdenx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathieu Bourdenx Line = papers co-authored together Mathieu Bourdenx links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations The Lancet Neurology ·Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, Serge Przedborski, Miquel Vila, Stéphane Hunot, Andrew Singleton, C. Warren Olanow, Kalpana Merchant, Erwan Bézard, Gregory A. Petsko, Wassilios G. Meissner Hit paper breakdown →	2015	388
2	The different autophagy degradation pathways and neurodegeneration Neuron ·Angeleen Fleming, Mathieu Bourdenx, Motoki Fujimaki, Cansu Karabiyik, Gregory J. Krause, Ana López, Adrián Martín‐Segura, Claudia Puri, Aurora Scrivo, John Skidmore, Sung Min Son, Eleanna Stamatakou, Lidia Wróbel, Ye Zhu, Ana María Cuervo, David C. Rubinsztein Hit paper breakdown →	2022	293
3	Selective autophagy as a potential therapeutic target for neurodegenerative disorders The Lancet Neurology ·Aurora Scrivo, Mathieu Bourdenx, Olatz Pampliega, Ana María Cuervo Hit paper breakdown →	2018	276
4	Proteome-wide analysis of chaperone-mediated autophagy targeting motifs PLoS Biology ·Philipp Kirchner, Mathieu Bourdenx, Julio Madrigal‐Matute, Simoni Tiano, Antonio Díaz, Boris Bartholdy, Britta Will, Ana María Cuervo	2019	162
5	Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases Autophagy ·Mathieu Bourdenx, Jonathan Daniel, Emilie Génin, Federico N. Soria, Mireille Blanchard‐Desce, Erwan Bézard, Benjamin Dehay	2016	160
6	Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies Progress in Neurobiology ·Mathieu Bourdenx, Nikolaos Stavros Koulakiotis, Despina Sanoudou, Erwan Bézard, Benjamin Dehay, Anthony Tsarbopoulos	2015	143
7	Exosomes, an Unmasked Culprit in Neurodegenerative Diseases Frontiers in Neuroscience ·Federico N. Soria, Olatz Pampliega, Mathieu Bourdenx, Wassilios G. Meissner, Erwan Bézard, Benjamin Dehay	2017	113
8	In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains Neurobiology of Disease ·Fabio Cavaliere, Loïc Cerf, Benjamin Dehay, Paula Ramos‐Gonzalez, Francesca De Giorgi, Mathieu Bourdenx, Alban Bessede, José Á. Obeso, Carlos Matute, François Ichas, Erwan Bézard	2017	91
9	Lysosomes and Î±-synuclein form a dangerous duet leading to neuronal cell death Frontiers in Neuroanatomy ·Mathieu Bourdenx, Erwan Bézard, Benjamin Dehay	2014	72
10	Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA–Induced Dyskinesia Biological Psychiatry ·Michel Engeln, Matthieu F. Bastide, Estelle Toulmé, Benjamin Dehay, Mathieu Bourdenx, Évelyne Doudnikoff, Qin Li, Christian E. Gross, Éric Boué‐Grabot, Antonio Pisani, Erwan Bézard, Pierre‐Olivier Fernagut	2014	64
11	Systemic gene delivery to the central nervous system using Adeno-associated virus Frontiers in Molecular Neuroscience ·Mathieu Bourdenx, Nathalie Dutheil, Erwan Bézard, Benjamin Dehay	2014	64
12	Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies JCI Insight ·Marie-Laure Arotçarena, Mathieu Bourdenx, Nathalie Dutheil, Marie-Laure Thiolat, Évelyne Doudnikoff, Sandra Doveró, Andrea Ballabio, Pierre‐Olivier Fernagut, Wassilios G. Meissner, Erwan Bézard, Benjamin Dehay	2019	56
13	Reciprocal regulation of chaperone-mediated autophagy and the circadian clock Nature Cell Biology ·Yves R. Juste, Susmita Kaushik, Mathieu Bourdenx, Ranee Aflakpui, Sanmay Bandyopadhyay, Fernando Garcı́a, Antonio Díaz, Kristen Lindenau, Vincent Tu, Gregory J. Krause, Maryam Jafari, Rajat Singh, Javier Muñoz, Fernando Macián, Ana María Cuervo	2021	51
14	Chaperone-mediated autophagy: a gatekeeper of neuronal proteostasis Autophagy ·Mathieu Bourdenx, Evripidis Gavathiotis, Ana María Cuervo	2021	36
15	Targeting α‐synuclein: Therapeutic options Movement Disorders ·Benjamin Dehay, Mickaël Decressac, Mathieu Bourdenx, Irene Guadagnino, Pierre‐Olivier Fernagut, Anna Tamburrino, Fares Bassil, Wassilios G. Meissner, Erwan Bézard	2016	30
16	mTORC2–NDRG1–CDC42 axis couples fasting to mitochondrial fission Nature Cell Biology ·Nuria Martínez-López, Pamela Mattar, Míriam Toledo, Henrietta Bains, Manu Kalyani, Marie Louise Aoun, Mridul Sharma, Laura Beth McIntire, Leslie Gunther-Cummins, Frank Macaluso, Jennifer T. Aguilan, Simone Sidoli, Mathieu Bourdenx, Rajat Singh	2023	25
17	What lysosomes actually tell us about Parkinson’s disease? Ageing Research Reviews ·Mathieu Bourdenx, Benjamin Dehay	2016	22
18	CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination eLife ·Hannah R. Monday, Mathieu Bourdenx, Bryen A. Jordan, Pablo E. Castillo	2020	21
19	Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease PLoS Biology ·Rikesh M. Rajani, Robert Ellingford, Mariam Hellmuth, Sam Harris, Orjona Taso, David Graykowski, Francesca Kar Wey Lam, Charles Arber, Emre Fertan, John S. H. Danial, Matthew Swire, Marcus Lloyd, Tatiana A. Giovannucci, Mathieu Bourdenx, David Klenerman, Robert Vassar, Selina Wray, Carlo Sala Frigerio, Marc Aurel Busche	2024	21
20	Lack of spontaneous age-related brain pathology in Octodon degus: a reappraisal of the model Scientific Reports ·Mathieu Bourdenx, Sandra Doveró, Marie-Laure Thiolat, Erwan Bézard, Benjamin Dehay	2017	21

About Mathieu Bourdenx

Mathieu Bourdenx is a scholar working on Aging, Neurology, Neurology, Physiology and Cellular and Molecular Neuroscience, having authored 32 papers that have together received 2.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (10 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Neurological disorders and treatments (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Autophagy in Disease and Therapy (5 papers), Lysosomal Storage Disorders Research (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Neurology (725 citations), Neurology (296 citations), Aging (48 citations), Physiology (119 citations) and Physiology (631 citations). Mathieu Bourdenx has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Benjamin Dehay, Erwan Bézard, Ana María Cuervo, Olatz Pampliega, Aurora Scrivo, Wassilios G. Meissner, Federico N. Soria, Miquel Vila, Serge Przedborski and Philippe Gorry. Their work appears in journals such as Neurobiology of Disease, Autophagy, Scientific Reports, Nature Cell Biology and PLoS Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact